US biotech firm Terns Pharmaceuticals sees potential 5-fold stock increase on promising obesity drug developments and analyst optimism
#YonhapInfomax #TernsPharmaceuticals #ObesityDrug #GLP1 #StockForecast #BiotechIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=53550